Economic evaluation in chronic pain: a systematic review and de novo flexible economic model
- PMID: 26377997
- PMCID: PMC4899502
- DOI: 10.1007/s10198-015-0720-y
Economic evaluation in chronic pain: a systematic review and de novo flexible economic model
Abstract
There is unmet need in patients suffering from chronic pain, yet innovation may be impeded by the difficulty of justifying economic value in a field beset by data limitations and methodological variability. A systematic review was conducted to identify and summarise the key areas of variability and limitations in modelling approaches in the economic evaluation of treatments for chronic pain. The results of the literature review were then used to support the development of a fully flexible open-source economic model structure, designed to test structural and data assumptions and act as a reference for future modelling practice. The key model design themes identified from the systematic review included: time horizon; titration and stabilisation; number of treatment lines; choice/ordering of treatment; and the impact of parameter uncertainty (given reliance on expert opinion). Exploratory analyses using the model to compare a hypothetical novel therapy versus morphine as first-line treatments showed cost-effectiveness results to be sensitive to structural and data assumptions. Assumptions about the treatment pathway and choice of time horizon were key model drivers. Our results suggest structural model design and data assumptions may have driven previous cost-effectiveness results and ultimately decisions based on economic value. We therefore conclude that it is vital that future economic models in chronic pain are designed to be fully transparent and hope our open-source code is useful in order to aspire to a common approach to modelling pain that includes robust sensitivity analyses to test structural and parameter uncertainty.
Keywords: Chronic pain; Economic evaluation; Modelling assumptions; Transparency.
Figures







Similar articles
-
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080. Health Technol Assess. 2006. PMID: 16545207
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Management of frozen shoulder: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2012;16(11):1-264. doi: 10.3310/hta16110. Health Technol Assess. 2012. PMID: 22405512 Free PMC article.
-
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090. Health Technol Assess. 2006. PMID: 16545208
Cited by
-
Transparency in Health Economic Modeling: Options, Issues and Potential Solutions.Pharmacoeconomics. 2019 Nov;37(11):1349-1354. doi: 10.1007/s40273-019-00842-0. Pharmacoeconomics. 2019. PMID: 31591672
-
Race differences in pain and pain-related risk factors among former professional American-style football players.Pain. 2023 Oct 1;164(10):2370-2379. doi: 10.1097/j.pain.0000000000002948. Epub 2023 Jun 9. Pain. 2023. PMID: 37314441 Free PMC article.
-
Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations.J Pain. 2023 Feb;24(2):204-225. doi: 10.1016/j.jpain.2022.08.010. Epub 2022 Oct 2. J Pain. 2023. PMID: 36198371 Free PMC article. Review.
-
Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.Med Decis Making. 2020 Apr;40(3):314-326. doi: 10.1177/0272989X20912402. Epub 2020 Apr 16. Med Decis Making. 2020. PMID: 32297840 Free PMC article.
-
Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients.Drugs. 2021 Jul;81(11):1257-1272. doi: 10.1007/s40265-021-01515-z. Epub 2021 Jul 1. Drugs. 2021. PMID: 34196947 Free PMC article.
References
-
- Merskey, H., Bogduk, N: Classification of chronic pain. IASP task force on taxonomy. International Association for the Study of Pain Press, Seattle, WA (1994). http://www.iasp-pain.org
-
- World Health Organization: WHO’s cancer pain ladder for adults.http://www.who.int/cancer/palliative/painladder/en/ (2014). Accessed 10 Sept 2014
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical